XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.2
STOCK - BASED COMPENSATION
6 Months Ended
Jun. 26, 2022
Share-Based Payment Arrangement [Abstract]  
STOCK - BASED COMPENSATION STOCK-BASED COMPENSATION
2021 Equity Incentive Plan

In connection with the Company’s IPO, the Company adopted the 2021 Equity Incentive Plan (the “2021 Plan”), which allows for issuance of stock options (including incentive stock options and non-qualified stock options), RSUs, including performance-based awards, and other types of awards. The maximum number of shares of common stock that may be issued under the 2021 Plan is 35,166,753, which is the sum of (i) 11,500,000 new shares, plus (ii) an additional number of shares consisting of (a) shares that were available for the issuance of awards under any prior equity incentive plans in place (which shall include the Prior Stock Plans (as defined below) and the options to purchase certain shares of common stock, assumed by the Company, pursuant to the Spyce Food Co. 2016 Stock Option and Grant Plan, prior to the time the Company’s 2021 Plan became effective and (b) any shares of the Company’s common stock subject to outstanding stock options or other stock awards granted under the Prior Stock Plans that on or after the Company’s 2021 Plan became effective, terminate or expire prior to the exercise or settlement; are not issued because the award is settled in cash; are forfeited because of the failure to vest; or are reacquired or withheld (or not issued) to satisfy a tax withholding obligation or the purchase or exercise price. Options granted during, or prior to, the thirteen and twenty-six weeks ended June 26, 2022 generally have vesting terms between twelve months and four years and have a contractual life of 10 years.

2009 Stock Plan and 2019 Equity Incentive Plan

Prior to the Company’s IPO, the Company granted stock options, RSUs and performance-based restricted stock awards (“PSUs”) to its employees, as well as nonemployees (including directors and others who provide substantial services to the Company) under the Company’s 2009 Stock Plan and 2019 Equity Incentive Plan (collectively, the “Prior Stock Plans”). Awards permitted to be granted under the Prior Stock Plans include incentive stock options to the Company’s employees and non-qualified stock options to the Company’s employees and non-employees, as well as stock appreciation rights, restricted stock awards, RSUs (including PSUs), and other forms of stock awards to the Company’s employees, directors and consultants and any of the Company’s affiliated employees and consultants. Options granted during the thirteen and twenty-six weeks ended June 26, 2022 and prior generally have vesting terms between one year and four years and have a contractual life of 10 years. No further stock awards will be granted under the Prior Stock Plans now that the 2021 Equity Incentive Plan is effective; however, awards outstanding under the Prior Stock Plans will continue to be governed by their existing terms.

Spyce Acquisition

In conjunction with the Spyce acquisition, the Company issued shares of Class S stock which converted to the Class A common stock upon the Company’s IPO. See Note 6. Shares of Class S stock that were issued to certain Spyce employees, and the corresponding shares of Class A common stock received by such
employees in connection with the Company’s IPO, are subject to time-based service requirements and will vest on September 7, 2023, subject to vesting acceleration in full upon the occurrence of certain events. As the value is fixed, the grant date fair value of these shares represents the fair value of the shares on the acquisition date. For the thirteen and twenty-six weeks ended June 26, 2022, the Company recognized stock-based compensation expense of $0.8 million and $1.7 million, respectively, related to the vested portion of such shares.

2021 Employee Stock Purchase Plan

In conjunction with the IPO, the Company’s board of directors adopted, and the Company’s stockholders approved the Company’s 2021 employee stock purchase plan (the “ESPP”). The Company’s ESPP authorizes the issuance of 3,000,000 shares of common stock under purchase rights granted to the Company’s employees or to the employees of any of its designated affiliates. The number of shares of the Company’s common stock reserved for issuance will automatically increase on January 1 of each year for a period of 10 years, beginning January 1, 2023, by the lesser of (i) 1% of the total number of shares of our common stock outstanding on December 31 of the immediately preceding year; and (ii) 4,300,000 shares, except before the date of any such increase, the Company’s board of directors may determine that such increase will be less than the amount set forth in clauses (i) and (ii).

As of June 26, 2022, there had been no offering period or purchase period under the ESPP, and no such period will begin unless and until determined by the administrator.
Stock Options

Certain amounts for employee stock option disclosures in prior years were reclassified to conform with current year presentation. The following table summarizes the Company’s stock option activity for the twenty-six weeks ended June 26, 2022 and June 27, 2021:
(dollar amounts in thousands except per share amounts)
Number of
Shares
Weighted
Average
Exercise
Price Per
Share
Weighted-Average
Remaining
Contractual Term
(In Years)
Aggregate
Intrinsic
Value
Balance—December 26, 202113,773,414$6.87 7.42$337,269 
Options granted578,86523.75 
Options exercised(560,610)5.22 
Options forfeited(130,590)12.24 
Options expired(25,243)5.85 
Balance—June 26, 202213,635,836$7.61 7.21$84,673 
Exercisable—June 26, 20228,824,027$5.35 6.35$70,585 
Vested and expected to vest—June 26, 202213,635,836$7.61 7.21$84,673 
(dollar amounts in thousands except per share amounts)
Number of
Shares
Weighted
Average
Exercise
Price Per
Share
Weighted-Average
Remaining
Contractual Term
(In Years)
Aggregate
Intrinsic
Value
Balance—December 27, 202014,612,730$4.27 6.34$15,204 
Options granted4,477,36010.76 
Options exercised(904,159)4.15 
Options forfeited(196,175)6.09 
Options expired(75,535)5.87 
Balance—June 27, 202117,914,221$6.12 7.07$71,852 
Exercisable—June 27, 20215,044,682$3.00 4.79$39,244 
Vested and expected to vest—June 27, 202117,914,221$6.12 7.07$71,852 
The weighted-average fair value of options granted during the twenty-six weeks ended June 26, 2022 and twenty-six weeks ended June 27, 2021, was $10.57 and $4.56, respectively.
The fair value of each option granted has been estimated as of the date of the grant using the Black-Scholes option-pricing model. The Company has elected to account for forfeitures as they occur.
As of June 26, 2022, there was $25.3 million in unrecognized compensation expense related to unvested stock-based compensation arrangements and is expected to be recognized over a weighted average period 2.32 years.

Restricted Stock Units and Performance Stock Units

Restricted stock units

The following table summarizes the Company’s RSU activity for the twenty-six weeks ended June 26, 2022:
(dollar amounts in thousands except per share amounts)
Number of SharesWeighted-Average Grant Date Fair Value
Balance—December 26, 20212,392,426 $24.18 
   Granted439,764 22.45 
   Released(57,084)19.65 
   Forfeited, cancelled, or expired(158,022)27.41 
Balance—June 26, 2022
2,617,084 $23.86 

There were no RSUs granted during the twenty-six weeks ended June 27, 2021.

As of June 26, 2022, unrecognized compensation expense related to RSUs was $45.5 million and is expected to be recognized over a weighted average period of 1.58 years. The fair value of shares released as of the vesting date during the twenty-six weeks ended June 26, 2022 was $1.3 million.

Performance stock units

In October 2021, the Company granted 2,100,000 PSUs to each founder (the “founder PSUs”) for a total of 6,300,000 PSUs, under the 2019 Equity Incentive Plan. The founder PSUs vest upon the satisfaction of a service condition and the achievement of certain stock price goals.

Subsequent to the Company’s IPO, the Company issued 321,428 PSUs to the Spyce founders (“Spyce PSUs”) based on three separate performance-based milestone targets. During the twenty-six weeks ended June 26, 2022, the Company has not recorded any stock-based compensation expense related to the Spyce PSUs, as no expense will be recognized until the targets are probable of being met. Unrecognized compensation expense related to the Spyce PSUs was $9.8 million, which will be expensed if the performance-based milestones targets become probable of being met.

There were no additional PSU grants during the twenty-six weeks ended June 26, 2022.

As of June 26, 2022 unrecognized compensation expense related to the founder PSUs was $78.7 million and is expected to recognized over a weighted average period of 2.48 years.

A summary of stock-based compensation expense recognized during the thirteen and twenty-six weeks ended June 26, 2022 and June 27, 2021 is as follows:

Thirteen weeks endedTwenty-six weeks ended
(dollar amounts in thousands)June 26,
2022
June 27,
2021
June 26,
2022
June 27,
2021
Stock-options$2,567 $1,877 $5,099 $3,099 
Restricted stock units11,592 22,176 
Performance stock units9,048 18,097 
Total stock-based compensation$23,207 $1,877 $45,372 $3,099